naion and semaglutide Semaglutide-suspected cases reported globally (Upon reviewing Newest Semaglutide/NAION Study Supports Hypothesis
Description
The Ozempic Blindness Concern Heres what we know so far: The risk is rare, but real

Consumers using GLP-1 weight-loss drugs make more grocery shopping trips beyond traditional food, mass and drug stores
%3A%20risk%20of%20Non-arteritic%20Anterior%20Ischemic%20Optic%20Neuropathy%20(NAION)/rgba(188%2C%2049%2C%20123%2C%201)/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention

Bleeding in the eye: Bleeding in the vitreous (the clear, gel-like substance located in the eye) caused by diabetes, hypertension, or injury can lead to floaters

Jadav P., Bahekar R., Shah S

Furthermore, absorption is specific to the compounds used: for example, liraglutide is not absorbed when co-formulated with SNAC, likely because it is too hydrophobic
